Massachusetts General Hospital: Metabolic Diseases trials
The registry lists 10 Metabolic Diseases studies with Massachusetts General Hospital as lead sponsor. 3 are open to participants now and 2 have results posted.
Phase 1 2Phase 2 1Phase 4 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Metabolism Enhancement by Laser TherapyNot yet recruitingNCT06899958Not applicable
- Improving Coronary Vascular Health in WomenRecruitingNCT06843902Phase 2
- GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHRecruitingNCT06003153Phase 4
- Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance TestCompletedNCT04958109Phase 1Results posted
- PREMIER: PREvention of Metabolic Illness Through prEcision nutRitionCompletedNCT04148482Not applicableResults posted
- Evaluation of Kisspeptin Stimulated Insulin Secretion With Hyperglycemic ClampWithdrawnNCT05456854Phase 1
- In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early LifeCompletedNCT04921241
- Effects of Gender-Affirming Hormone Therapy Among Transgender WomenCompletedNCT04128488
- Identification of Undiagnosed Lysosomal Acid Lipase DeficiencyStatus unknownNCT01716728Not applicable
- Study of Lifestyle Modification in HIV LipodystrophyCompletedNCT00111358Not applicable